These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7724017)

  • 1. Ondansetron for symptomatic relief in terminal uraemia.
    Andrews PA; Quan V; Ogg CS
    Nephrol Dial Transplant; 1995; 10(1):140. PubMed ID: 7724017
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting.
    Ljutić D; Perković D; Rumboldt Z; Bagatin J; Hozo I; Pivac N
    Kidney Blood Press Res; 2002; 25(1):61-4. PubMed ID: 11834879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron.
    Thavaraj V; Arya LS
    Indian Pediatr; 1995 Aug; 32(8):898-901. PubMed ID: 8635834
    [No Abstract]   [Full Text] [Related]  

  • 4. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
    Goldsmith B
    Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
    Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT3 receptor antagonists ameliorate emesis in the ferret evoked by neutron or proton radiation.
    King GL; Rabin BM; Weatherspoon JK
    Aviat Space Environ Med; 1999 May; 70(5):485-92. PubMed ID: 10332945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of ondansetron for undifferentiated nausea and vomiting in the prehospital setting.
    Warden CR; Moreno R; Daya M
    Prehosp Emerg Care; 2008; 12(1):87-91. PubMed ID: 18189184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ondansetron for postoperative nausea and vomiting: decisions in the absence of comparative trials.
    Lewis MA; Fishman DA
    Am J Hosp Pharm; 1994 Feb; 51(4):524-5. PubMed ID: 8017423
    [No Abstract]   [Full Text] [Related]  

  • 9. Ondansetron for postoperative nausea and vomiting.
    Woodward M; Gora ML
    Ann Pharmacother; 1993 Feb; 27(2):188-9. PubMed ID: 8439697
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of ondansetron for prevention of postoperative nausea and vomiting after outpatient ear surgery under local anesthesia.
    Ku PK; Tong MC; Lo P; van Hasselt CA
    Am J Otol; 2000 Jan; 21(1):24-7. PubMed ID: 10651430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of ondansetron for chemotherapy-induced nausea and emesis.
    San Angel F
    J Intraven Nurs; 1993; 16(2):84-9. PubMed ID: 8478782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ondansetron in the treatment of intractable nausea associated with theophylline toxicity.
    Sage TA; Jones WN; Clark RF
    Ann Pharmacother; 1993 May; 27(5):584-5. PubMed ID: 8347909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy.
    Bloch J; Rixe O; Meric JB; Delgado A; Khayat D
    Curr Med Res Opin; 2005 Nov; 21(11):1763-71. PubMed ID: 16307696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of postoperative nausea and vomiting with ondansetron in patients administered anti-neoplastic agents].
    Morimoto Y; Nakamura M; Tamura T; Kunii T; Shimizu K; Miyauchi Y
    Masui; 1996 Sep; 45(9):1096-9. PubMed ID: 8905945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The management of vomiting and nausea with zofran during the chemotherapy of malignant tumors].
    Seliuzhitskiĭ IV; Eliseev SN; Ivanov AI
    Voen Med Zh; 1994 Oct; (10):34-6. PubMed ID: 7831851
    [No Abstract]   [Full Text] [Related]  

  • 16. Ondansetron: perioperative use of a serotonin receptor antagonist for the prevention and treatment of nausea and vomiting.
    Early TE; Charbonneau J; McKnight G; Jenkins P
    J Post Anesth Nurs; 1995 Dec; 10(6):320-3. PubMed ID: 8632370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ondansetron: indications and applications in the paediatric intensive care unit.
    Tobias JD
    Anaesth Intensive Care; 1992 Nov; 20(4):504-6. PubMed ID: 1463183
    [No Abstract]   [Full Text] [Related]  

  • 18. Intraperitoneal ondansetron hydrochloride for intractable nausea and vomiting due to diabetic gastroparesis in a patient on peritoneal dialysis.
    Amin K; Bastani B
    Perit Dial Int; 2002; 22(4):539-40. PubMed ID: 12322834
    [No Abstract]   [Full Text] [Related]  

  • 19. No more than necessary: safety and efficacy of low-dose promethazine.
    Moser JD; Caldwell JB; Rhule FJ
    Ann Pharmacother; 2006 Jan; 40(1):45-8. PubMed ID: 16352779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ondansetron in the treatment of nausea and vomiting. Introduction.
    Marschner N
    Anticancer Drugs; 1993 Dec; 4 Suppl 2():3-7. PubMed ID: 8136513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.